Paper40565229
Peptide-Engineered Seliciclib Nanomedicine for Brain-Targeted Delivery and Neuroprotection.
He GZ and 1 other. Int J Mol Sci, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Peptide-Engineered Seliciclib Nanomedicine for Brain-Targeted Delivery and Neuroprotection. Papers, record 40565229. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40565229
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Peptide-Engineered Seliciclib Nanomedicine for Brain-Targeted Delivery and Neuroprotection.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neuroprotective Agents | Major topic |
| Brain | Major topic |
| Peptides | Major topic |
| Neuroprotection | Major topic |
| Animals | |
| Humans | |
| Blood-Brain Barrier | |
| Mice | |
| Nanomedicine | |
| Nanoparticles | |
| Tissue Distribution | |
| Cell Line, Tumor | |
| Drug Delivery Systems | |
| Cell Line | |
| Male |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| MOST 109-2320-B-002-046-MY3 | National Science and Technology Council | PubMed |
Source PubMed
References56
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36297647 | Development of WRAP5 Peptide Complexes for Targeted Drug/Gene Co-Delivery toward Glioblastoma Therapy. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/36297647 | PubMed |
| 2 | 27374198 | Brain tumor-targeted therapy by systemic delivery of siRNA with Transferrin receptor-mediated core-shell nanoparticles. | Int J Pharm | 2016 | https://conductscience.org/library/papers/27374198 | PubMed |
| 3 | 37242623 | Non-Invasive, Targeted Nanoparticle-Mediated Drug Delivery across a Novel Human BBB Model. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37242623 | PubMed |
| 4 | 26826308 | Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors. | J Control Release | 2016 | https://conductscience.org/library/papers/26826308 | PubMed |
| 5 | 31995153 | Vps35 Deficiency Impairs Cdk5/p35 Degradation and Promotes the Hyperphosphorylation of Tau Protein in Retinal Ganglion Cells. | Invest Ophthalmol Vis Sci | 2020 | https://conductscience.org/library/papers/31995153 | PubMed |
| 6 | 20380819 | Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies. | Brain Res | 2010 | https://conductscience.org/library/papers/20380819 | PubMed |
| 7 | 39608455 | Minocycline nanoplatform penetrates the BBB and enables the targeted treatment of Parkinson's disease with cognitive impairment. | J Control Release | 2025 | https://conductscience.org/library/papers/39608455 | PubMed |
| 8 | 27208862 | Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases. | J Control Release | 2016 | https://conductscience.org/library/papers/27208862 | PubMed |
| 9 | 22830613 | Roscovitine sensitizes leukemia and lymphoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. | Leuk Lymphoma | 2013 | https://conductscience.org/library/papers/22830613 | PubMed |
| 10 | 15111235 | Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists. | Neurotox Res | 2004 | https://conductscience.org/library/papers/15111235 | PubMed |
| 11 | 28118852 | The SH-SY5Y cell line in Parkinson's disease research: a systematic review. | Mol Neurodegener | 2017 | https://conductscience.org/library/papers/28118852 | PubMed |
| 12 | 11277922 | Receptor mediated uptake of peptides that bind the human transferrin receptor. | Eur J Biochem | 2001 | https://conductscience.org/library/papers/11277922 | PubMed |
| 13 | 35646531 | The long-circulating effect of pegylated nanoparticles revisited via simultaneous monitoring of both the drug payloads and nanocarriers. | Acta Pharm Sin B | 2022 | https://conductscience.org/library/papers/35646531 | PubMed |
| 14 | 37376196 | Novel Human/Non-Human Primate Cross-Reactive Anti-Transferrin Receptor Nanobodies for Brain Delivery of Biologics. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37376196 | PubMed |
| 15 | 28629814 | Abcb1a (P-glycoprotein) limits brain exposure of the anticancer drug candidate seliciclib in vivo in adult mice. | Brain Res Bull | 2017 | https://conductscience.org/library/papers/28629814 | PubMed |
| 16 | 38857748 | Blood brain barrier-targeted lipid nanoparticles improved the neuroprotection of Ferrostatin-1 against cerebral ischemic damage in an experimental stroke model. | Exp Neurol | 2024 | https://conductscience.org/library/papers/38857748 | PubMed |
| 17 | 31189016 | Overexpression of the Cdk5 inhibitory peptide in motor neurons rescue of amyotrophic lateral sclerosis phenotype in a mouse model. | Hum Mol Genet | 2019 | https://conductscience.org/library/papers/31189016 | PubMed |
| 18 | 17286588 | Dopaminergic neurons intrinsic to the striatum. | J Neurochem | 2007 | https://conductscience.org/library/papers/17286588 | PubMed |
| 19 | 39336425 | Nanomedicine in Neuroprotection, Neuroregeneration, and Blood-Brain Barrier Modulation: A Narrative Review. | Medicina (Kaunas) | 2024 | https://conductscience.org/library/papers/39336425 | PubMed |
| 20 | 33396266 | The Role of CDK5 in Tumours and Tumour Microenvironments. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/33396266 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CDK5 | 1020 | PubTator's text mining | https://conductscience.org/library/genes/1020 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40565229
GET https://conductscience.org/api/papers/v1/40565229/references?page=2